Noncompetitive excitatory amino acid receptor antagonists

David Lodge, Kenneth M. Johnson

Research output: Contribution to journalArticle

309 Citations (Scopus)

Abstract

In the first article in this series, Watkins, Krogsgaard-Larsen and Honoré outlined the structure-activity requirements at the receptor sites for excitatory amino acids in the mammalian CNS. The postsynaptic depolarizing actions of glutamate are thought to be mediated by NMDA, AMPA and kainate receptors. Here David Lodge and Kenneth M. Johnson review some of the recent developments in the pharmacology of other means by which the function of these receptors may be modulated. Divalent cations, phencyclidine-like drugs, glycine analogues and polyamines all modulate NMDA receptors whereas barbiturates and some arthropod toxins reduce channel responses to non-NMDA receptor agonists. Modes of action and implications for physiology and pathophysiology are discussed.

Original languageEnglish (US)
Pages (from-to)81-86
Number of pages6
JournalTrends in Pharmacological Sciences
Volume11
Issue number2
DOIs
StatePublished - 1990

Fingerprint

Excitatory Amino Acid Antagonists
Glutamate Receptors
N-Methyl-D-Aspartate Receptors
Kainic Acid Receptors
Phencyclidine
Excitatory Amino Acids
Barbiturates
AMPA Receptors
Arthropods
Divalent Cations
Physiology
Polyamines
Glycine
Glutamic Acid
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Noncompetitive excitatory amino acid receptor antagonists. / Lodge, David; Johnson, Kenneth M.

In: Trends in Pharmacological Sciences, Vol. 11, No. 2, 1990, p. 81-86.

Research output: Contribution to journalArticle

Lodge, David ; Johnson, Kenneth M. / Noncompetitive excitatory amino acid receptor antagonists. In: Trends in Pharmacological Sciences. 1990 ; Vol. 11, No. 2. pp. 81-86.
@article{895baf4a6c9f41de8f507b448f0dd05d,
title = "Noncompetitive excitatory amino acid receptor antagonists",
abstract = "In the first article in this series, Watkins, Krogsgaard-Larsen and Honor{\'e} outlined the structure-activity requirements at the receptor sites for excitatory amino acids in the mammalian CNS. The postsynaptic depolarizing actions of glutamate are thought to be mediated by NMDA, AMPA and kainate receptors. Here David Lodge and Kenneth M. Johnson review some of the recent developments in the pharmacology of other means by which the function of these receptors may be modulated. Divalent cations, phencyclidine-like drugs, glycine analogues and polyamines all modulate NMDA receptors whereas barbiturates and some arthropod toxins reduce channel responses to non-NMDA receptor agonists. Modes of action and implications for physiology and pathophysiology are discussed.",
author = "David Lodge and Johnson, {Kenneth M.}",
year = "1990",
doi = "10.1016/0165-6147(90)90323-Z",
language = "English (US)",
volume = "11",
pages = "81--86",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Noncompetitive excitatory amino acid receptor antagonists

AU - Lodge, David

AU - Johnson, Kenneth M.

PY - 1990

Y1 - 1990

N2 - In the first article in this series, Watkins, Krogsgaard-Larsen and Honoré outlined the structure-activity requirements at the receptor sites for excitatory amino acids in the mammalian CNS. The postsynaptic depolarizing actions of glutamate are thought to be mediated by NMDA, AMPA and kainate receptors. Here David Lodge and Kenneth M. Johnson review some of the recent developments in the pharmacology of other means by which the function of these receptors may be modulated. Divalent cations, phencyclidine-like drugs, glycine analogues and polyamines all modulate NMDA receptors whereas barbiturates and some arthropod toxins reduce channel responses to non-NMDA receptor agonists. Modes of action and implications for physiology and pathophysiology are discussed.

AB - In the first article in this series, Watkins, Krogsgaard-Larsen and Honoré outlined the structure-activity requirements at the receptor sites for excitatory amino acids in the mammalian CNS. The postsynaptic depolarizing actions of glutamate are thought to be mediated by NMDA, AMPA and kainate receptors. Here David Lodge and Kenneth M. Johnson review some of the recent developments in the pharmacology of other means by which the function of these receptors may be modulated. Divalent cations, phencyclidine-like drugs, glycine analogues and polyamines all modulate NMDA receptors whereas barbiturates and some arthropod toxins reduce channel responses to non-NMDA receptor agonists. Modes of action and implications for physiology and pathophysiology are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0025186752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025186752&partnerID=8YFLogxK

U2 - 10.1016/0165-6147(90)90323-Z

DO - 10.1016/0165-6147(90)90323-Z

M3 - Article

VL - 11

SP - 81

EP - 86

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 2

ER -